BioCardia Inc logo

BioCardia Inc

1
0
NAS:BCDA (USA)  
$ 2.41 -0.21 (-7.98%) 07:08 PM EST
At Loss
Volume:
77.82K
Avg Vol (2M):
1.18M
Trade In:
Volume:
77.82K
At Loss
Avg Vol (2M):
1.18M

Business Description

Description
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
Name Current Vs Industry Vs History
Cash-To-Debt 1.25
Equity-to-Asset -0.68
Debt-to-Equity -0.58
Debt-to-EBITDA -0.13
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -85.14
Distress
Grey
Safe
Beneish M-Score -5.66
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 37.71
9-Day RSI 40.28
14-Day RSI 43.06
6-1 Month Momentum % -47.03
12-1 Month Momentum % -48.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.39
Quick Ratio 0.39
Cash Ratio 0.35
Days Sales Outstanding 59.7

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.2
Shareholder Yield % -48.12

Financials (Next Earnings Date:2024-11-08 Est.)

BCDA's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BCDA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

BioCardia Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.428
EPS (TTM) ($) -5.38
Beta 1.26
Volatility % 96.17
14-Day RSI 43.06
14-Day ATR ($) 0.234375
20-Day SMA ($) 2.61525
12-1 Month Momentum % -48.33
52-Week Range ($) 1.9562 - 23.249999
Shares Outstanding (Mil) 3.5

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BioCardia Inc Filings

Filing Date Document Date Form
No Filing Data

BioCardia Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

BioCardia Inc Frequently Asked Questions

What is BioCardia Inc(BCDA)'s stock price today?
The current price of BCDA is $2.41. The 52 week high of BCDA is $23.25 and 52 week low is $1.96.
When is next earnings date of BioCardia Inc(BCDA)?
The next earnings date of BioCardia Inc(BCDA) is 2024-11-08 Est..
Does BioCardia Inc(BCDA) pay dividends? If so, how much?
BioCardia Inc(BCDA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1